Showing 251-260 of 352 grants

Title Institution Researcher Program Duration Total Award Amount
Role of ZBED3 in beta cell stress response and vulnerability against autoimmunity Trustees of Indiana University Erica Cai Cures 01-June-2026 to 29-February-2028 $383.433,16
Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes Trustees of Indiana University Jamie Felton Cures 01-February-2026 to 31-January-2029 $682.534,00
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153.000,00
Design of Pump-Compatible Insulin-Glucagon Fusion Proteins Trustees of Indiana University Michael Weiss Improving Lives 01-April-2026 to 31-March-2027 $255.749,24
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900.000,00
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1.603.777,39
Engineering regulatory B cells to promote immune tolerance for islet cell replacement therapy: A novel opportunity to cure Type I diabetes Trustees of the University of Pennsylvania James Markmann Cures 01-October-2026 to 30-September-2029 $598.995,17
Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs Trustees of the University of Pennsylvania Ji Lei Cures 01-June-2025 to 31-May-2027 $749.999,08
A bioelectronics platform to standardize SC-islet maturation and model T1D autoimmunity Trustees of the University of Pennsylvania Juan Alvarez Cures 01-October-2026 to 30-September-2029 $1.049.999,94
An AI-driven bioelectronics system to accelerate SC-islet maturation Trustees of the University of Pennsylvania Juan Alvarez Cures 01-April-2025 to 01-March-2027 $200.000,00